Related Experiment Videos
[Acute pancreatitis: reliable and prospective conservative therapy]
Summary
Managing severe acute pancreatitis remains challenging. Current treatments focus on supportive care, with specific interventions like prophylactic antibiotics for necrotizing pancreatitis and ERCP for gallstone pancreatitis showing benefit. Promising new agents are under investigation.
Area of Science:
- Gastroenterology and Hepatology
- Critical Care Medicine
Context:
- Acute pancreatitis management is complex, with limited effective treatments for severe cases.
- Standard care includes volume resuscitation, nutritional support, and analgesia.
Purpose:
- To review current management strategies for acute pancreatitis.
- To highlight effective interventions and ineffective therapies.
- To introduce novel therapeutic agents under investigation for severe necrotizing pancreatitis.
Summary:
- Non-specific management involves fluid resuscitation, total parenteral nutrition, and pain relief.
- Prophylactic antibiotics are recommended for necrotizing pancreatitis; selective digestive tract decontamination is effective only with systemic antibiotics.
- ERCP and endoscopic sphincterotomy are indicated for severe gallstone pancreatitis. Agents like somatostatin and protease inhibitors have proven ineffective.
- Two trials are evaluating lexipafant and isovolemic hemodilution with dextran for severe necrotizing pancreatitis.
Impact:
- Identifies key interventions for specific pancreatitis subtypes.
- Discourages the use of ineffective treatments, optimizing resource allocation.
- Provides insight into emerging therapies for severe pancreatitis, potentially improving patient outcomes.